<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03218579</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-12-ZH-658-CTIL</org_study_id>
    <nct_id>NCT03218579</nct_id>
  </id_info>
  <brief_title>Endoscopic Assessment and Prediction of Microbiome-modifying Interventions</brief_title>
  <acronym>microbiome</acronym>
  <official_title>Endoscopic Assessment and Prediction of Microbiome-modifying Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Weizmann Institute of Science</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators would like to examine the extent of gut microbiome rehabilitation in
      healthy people after the consumption of antibiotics.

      Outcomes of probiotic treatment versus bacteriotherapy will be compared.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators would like to examine the extent of rehabilitation of the composition and
      functioning of the intestinal bacteria in healthy people after the consumption of
      antibiotics.

      Since the digestive mocus enables the connection between the host and the bacteria that live
      within it, the investigators would like to characterize the microbiome in the different areas
      along the digestive system - before antibiotic treatment and after rehabilitation by
      probiotic treatment versus bacteriotherapy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2013</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Microbiome composition</measure>
    <time_frame>1 year</time_frame>
    <description>stool samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microbiome composition</measure>
    <time_frame>1 month</time_frame>
    <description>Gastrointestinal tract biopsies</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Gut Microbiome</condition>
  <condition>Antibiotic Side Effect</condition>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention after antibiotic treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic microbiome rehabilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Probiotic treatment after antibiotic treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bacteriotherapy microbiome rehabilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bacteriotherapy after antibiotic treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic treatment</intervention_name>
    <description>4 weeks of probiotic treatment after 7 days of antibiotics (Metronidazole+Ciprofloxacin)</description>
    <arm_group_label>Probiotic microbiome rehabilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Bacteriotherapy</intervention_name>
    <description>Bacteriotherapy (autologous fecal microbiota transplantation) after 7 days of antibiotics (Metronidazole+Ciprofloxacin)</description>
    <arm_group_label>Bacteriotherapy microbiome rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

          -  Age: 18 years and up

          -  Gender: women and men

        Exclusion Criteria:

          -  Pregnancy

          -  Age under 18 years

          -  antibiotic treatment 3 months prior to enrollment

          -  Viral Hepatitis

          -  HIV positive
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zamir Halpern, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel-Aviv Sourasky Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Noya Horowitz, PhD</last_name>
    <phone>97236974297</phone>
    <email>noyah@tlvmc.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Gastroentherology</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zamir Halpern, MD</last_name>
      <phone>6974282</phone>
      <email>halpernza@tlvmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>Zamir Halpern, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Niv Zmora, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eran Elinav, M.D. Ph.D. A.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eran Segal, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2017</study_first_submitted>
  <study_first_submitted_qc>July 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2017</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>microbiome</keyword>
  <keyword>intestinal bacteria</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

